Metraipolis › archive › dc_f4e761c6ec16

Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response — Europe PMC PMID:42328454

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42328454
DOI
10.7150/ijbs.130955
License (as archived)
solo-consultazione
Archived
2026-10-07T18:33:09.616Z
SHA-256 of the archived text
8abbdd4874b876bf7b0f26ce2335e62322f4a446d4bd3371477773ba0f32a675
Stable URL of this page
https://metraipolis.com/documento/dc_f4e761c6ec16

How to cite

Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response — Europe PMC PMID:42328454 — Europe PMC (en), https://europepmc.org/article/MED/42328454 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f4e761c6ec16 (Metraipolis archive dc_f4e761c6ec16, sha256 8abbdd4874b876bf7b0f26ce2335e62322f4a446d4bd3371477773ba0f32a675)
BibTeX
@misc{dcf4e761c6ec16,
  title = {Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response — Europe PMC PMID:42328454},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42328454},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f4e761c6ec16; sha256 8abbdd4874b876bf7b0f26ce2335e62322f4a446d4bd3371477773ba0f32a675},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42328454. Agents can read the archived copy with the MCP tool read_document.